| 1 |
10402245 | The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1999 Aug |
1 |
| 2 |
10509151 | Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors. | 1999 Aug |
1 |
| 3 |
9167749 | Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer. | 1997 Jun |
2 |
| 4 |
9446257 | [Low-dose GM-CSF and dose intensity of antineoplastic agents]. | 1997 Sep-Oct |
1 |
| 5 |
8823488 | Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer. | 1996 |
3 |
| 6 |
8620409 | Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinoma. | 1995 Oct 15 |
1 |
| 7 |
8698741 | Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. | 1995 |
1 |
| 8 |
8153657 | Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate. | 1994 Feb |
1 |